MIRELLE IGNACIO: Open Payments
NPI 1639350416 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,702 in 42 payments from 15 companies in 2025. Trend: 2023 $1,170 · 2024 $1,819 · 2025 $1,702
Food & beverage: $1,702
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $443 |
| Novo Nordisk Inc | 7 | $326 |
| Lilly USA, LLC | 8 | $193 |
| AstraZeneca Pharmaceuticals LP | 3 | $159 |
| Exact Sciences Corporation | 5 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Galderma Laboratories, L.P. | 1 | $48 |
| Medtronic, Inc. | 1 | $45 |
Products named: BOTOX, QULIPTA, AIRSUPRA, Ozempic, MOUNJARO, VOQUEZNA, The Cologuard Plus Collection Kit, XIFAXAN.
Industry payments across CA — which companies pay providers there.
